[{"NetIncomeLoss_1_Q3_USD":-432034.0,"CommonStockSharesIssued_0_Q3_shares":23000000.0,"UnrecognizedTaxBenefits_0_Q3_USD":0.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q3_USD":230000000.0,"AssetsCurrent_0_Q3_USD":287110.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":300000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_3_Q3_USD":0.0,"AccruedLiabilitiesCurrent_0_Q3_USD":2625925.0,"GeneralAndAdministrativeExpense_1_Q3_USD":1472921.0,"GeneralAndAdministrativeExpense_3_Q3_USD":4141810.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"Assets_0_Q3_USD":230299733.0,"Liabilities_0_Q3_USD":25202318.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":200000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":961084.0,"FairValueAdjustmentOfWarrants_1_Q3_USD":-1138000.0,"FairValueAdjustmentOfWarrants_3_Q3_USD":-3523000.0,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q3_shares":5750000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"AssetsHeldInTrustNoncurrent_0_Q3_USD":230012623.0,"SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_0_Q3_shares":23000000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q3_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":2575925.0,"Cash_0_Q3_USD":204865.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"OperatingIncomeLoss_3_Q3_USD":-4448949.0,"NetIncomeLoss_3_Q3_USD":-867475.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_1_Q3_USD":52500.0,"RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_3_Q3_USD":157500.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":204865.0,"AccountsPayableCurrent_0_Q3_USD":961084.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":-712122.0,"LiabilitiesCurrent_0_Q3_USD":3634148.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-1012122.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-432034.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-867475.0,"CommonStockSharesOutstanding_0_Q3_shares":23000000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-24903160.0,"StockholdersEquity_0_Q3_USD":-24902585.0,"ProfitLoss_3_Q3_USD":-867475.0,"CashFDICInsuredAmount_0_Q3_USD":250000.0,"SharePrice_0_Q3_USD":10.0,"PreferredStockSharesAuthorized_0_Q3_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":230299733.0,"PreferredStockValue_0_Q3_USD":null,"InvestmentIncomeInterest_1_Q3_USD":5798.0,"InvestmentIncomeInterest_3_Q3_USD":58474.0,"OperatingIncomeLoss_1_Q3_USD":-1575832.0,"PrepaidExpenseCurrent_0_Q3_USD":82245.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":-70229.0,"Ticker":"TOI","CIK":"1799191","name":"DFP HEALTHCARE ACQUISITIONS CORP.","OfficialName":"The Oncology Institute Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"520068227.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NASDAQ","SP500":"nan","filed":"20211108"}]